A clinical trial at the Barbara Davis Center for Childhood Diabetes at the University of Colorado Anschutz Medical Center and three other pediatric diabetes centers in the United States has found that a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — is safe and effective at managing blood glucose levels in children as young as age six with type 1 diabetes. The trial was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. Results from the trial were published August 26 in the New England Journal of Medicine. 

Kelsea Pieters | August 27, 2020

A new study from the University of Colorado Anschutz Medical Campus challenges a decades-old hypothesis on adaptation, a key feature in how sensory cells of the inner ear (hair cells) detect sound.

Kelsea Pieters | August 14, 2020

Researchers at the University of Colorado School of Medicine have discovered a protein in fruit fly embryos, dubbed Marie Kondo, that destroys maternal proteins. Much like namesake, author and clutter consultant Marie Kondo, this gene removes unnecessary molecules, keeping embryos organized.

Kelsea Pieters | July 28, 2020

Peer mentorship is a critical and more accessible option for professional and personal growth than traditional mentor-mentee relationships, according to a new paper from the University of Colorado Anschutz Medical Campus.

Kelsea Pieters | July 23, 2020

The CU Healthcare Innovation Fund announced today that it has secured its maximum targeted committed capital of $50 million. The fund is affiliated with and located at the University of Colorado Anschutz Medical Campus near Denver.

Kelsea Pieters | July 07, 2020

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus today announced a large-scale research collaboration designed to advance the field of human genetics and precision medicine through the sharing of 450,000 DNA samples and corresponding health records from de-identified, consented patient participants in the expansive UCHealth system. The Regeneron Genetics Center (RGC), a wholly owned subsidiary of Regeneron, has entered into the collaboration with CCPM and will sequence these samples, producing genomic data that can be used to facilitate translational medical research and ultimately enable physicians to make better decisions for their patients. 

Kelsea Pieters | May 11, 2020

Researchers at the University of Colorado Anschutz Medical Campus have found that interest in abortion care among advance practice clinicians (APCs) in Colorado is substantial, though barriers must be addressed in order to increase access with APCs (nurse practitioners, nurse midwives, physician’s assistants).

Kelsea Pieters | April 23, 2020

Assessing adverse childhood experiences and current anxiety and depression symptoms may help ease cognitive distress in women who have undergone a surgical menopause for cancer risk-reduction, or RRSO, according to a new study published in Menopause.

Kelsea Pieters | March 26, 2020

Michelle Barron, MD, professor of medicine and an infectious diseases expert, responds to questions about COVID-19. She addresses what's myth and what's fact, how it's spread, how we can contain it and when to see a doctor. 

Kelsea Pieters | March 10, 2020

Knowing the amount of opioids taken following cesarean section surgery and before discharge can inform individualized prescriptions and cut down on unnecessary, leftover pills that could be used for non-medical purposes, according to a new study from the University of Colorado Anschutz Medical Campus.

Kelsea Pieters | March 09, 2020